Tiantian Zhang | Health Professions | Best Researcher Award

Posted on 02/12/202402/12/2024 by ScienceFather

Dr. Tiantian Zhang | Health Professions | Best Researcher Award

Dr. Tiantian Zhang, Fudan University, China

Dr. Tiantian Zhang is a dedicated researcher in the field of public health, specializing in the construction of public health systems and proactive health technologies within the context of medical health big data. Currently serving as a Youth Researcher at the School of Public Health at Fudan University since October 2023, she brings an academic background with a Master’s and Doctorate in Management, focusing on social medicine and health management from Fudan University. She has contributed significantly to over 38 publications, with many in high-impact journals, particularly in health policy, public health emergency responses, and chronic disease prevention. Her research also covers the intersection of technology, public health, and healthcare systems. She has been involved in various research projects and has received substantial funding for her work. Dr. Zhang’s academic journey includes postdoctoral research and entrepreneurial experience in management science and data science. Additionally, she is a key member of national projects on public health and disease prevention.

Publication Profile

Scopus

Academic Background 🎓📚

Dr. Tiantian Zhang pursued her graduate studies at Fudan University, where she earned a Master’s degree in Management with a focus on Social Medicine and Health Administration from September 2016 to June 2018. 🏫🎓 She continued her academic journey at Fudan, completing a PhD in Management in the same field from June 2018 to June 2021. 🔬 Her doctoral research contributed to advancing public health management and policy, further establishing her expertise in healthcare systems and social medicine. Dr. Zhang’s academic foundation laid the groundwork for her current work in public health and health data research. 🌟📊

Professional and Visiting Scholar Experience 💼🌍

Dr. Tiantian Zhang has held various esteemed positions in her career. Since October 2023, she has been serving as a Youth Researcher at Fudan University, focusing on Health Management. 🏫🧑‍🔬 From June 2021 to September 2023, she worked as a Postdoctoral Researcher at Fudan University, specializing in Public Policy. 📜🔍 Additionally, since September 2017, Dr. Zhang has been the founder and legal representative of Shanghai Haiyu Information Technology Co., Ltd., where she applies her expertise in Management Science and Data Science. 💻📊 Her diverse roles reflect her commitment to advancing healthcare and policy through innovation. 🌟

Research Achievements and Contributions 📚🏆

Dr. Tiantian Zhang, a Youth Researcher at Fudan University’s School of Public Health, has made significant contributions to healthcare management research. She has co-authored 9 policy briefs, receiving positive feedback from top political leaders, including members of the Central Political Bureau. 👩‍🔬✨ She has led a National Natural Science Foundation Youth Project and 7 provincial projects, while also contributing to major national R&D initiatives. Her research includes 37 published papers, 8 of which are in high-impact journals (SCI/SSCI, JCR-Q1), with a total impact factor of 68.5. 📝📊 Dr. Zhang has received multiple prestigious awards, including the Shanghai Decision-Making Advisory Research Awards and the Shanghai Youth Medal. 🏅

Academic Positions and Editorial Roles 📚🌟

Dr. Tiantian Zhang holds several prestigious academic roles. She is a Youth Elite Talent for the Shanghai Municipal Government Decision-Making Consulting Research Base (2024–2026) and an expert in Shanghai’s healthcare reform (2022–2025). 🏅 She serves on the Youth Committee of the Shanghai Medical Association’s Health Management Branch and is a director of the Chinese Medicine Informatics Society. 🩺 Additionally, she contributes to several academic journals, including Chinese Hospital Management and Chinese Public Health Management, where she holds youth editorial board positions. ✍️ She is also involved in writing and editing key publications, including the fifth edition of Health Management and the Blue Book on Proactive Health and Healthy Aging. 📖

Research Focus

Dr. Tiantian Zhang’s research focuses on public health management, health policy, and health data science. She is particularly interested in the intersection of healthcare system development and technology for proactive health and aging. 🏥 Her work includes studies on health equity, air pollution, dyslipidemia, and disease prevention, and she frequently contributes to research on health disparities and socioeconomic factors affecting public health. 🌍 Additionally, she explores health management practices and decision-making frameworks for improving healthcare services, with a strong emphasis on government regulation and community-based health interventions. 📊

Publication Top Notes

Association of circadian syndrome with risk of hyperuricemia among middle-aged and older adults in China – 2025 🕰️,
Research on government regulation methods for the spatial layout of retail pharmacies – 2024 🏪
Prevalence of dyslipidemia and associated factors in sedentary occupational population from Shanghai – 2024 ⚖️,
Global Justice Index Report 2023 – 2024 🌍, Cited by: 2 📑.
Association of long-term exposure to air pollutants with sensory impairment in middle-aged and elderly adults – 2024 🌫️
Equity analysis of older adult resource allocation in China – 2024 💼
Development of an assessment tool for designated medical institutions in China – 2024 💻
Association of indoor solid fuel use and long-term exposure to ambient PM2.5 with sarcopenia in China – 2023 🌫️, Cited by: 10 📑.
Global Justice Index Report 2022 – 2023 🌍, Cited by: 7 📑.

Chun-Feng Huang | Health Professions | Best Researcher Award

Posted on 26/11/202426/11/2024 by ScienceFather

Assist. Prof. Dr. Chun-Feng Huang | Health Professions | Best Researcher Award

Chief of Family Medicine at En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan

Dr. Chun-Feng Huang is an Assistant Professor at the National Yang Ming Chiao Tung University and the Chief of Family Medicine at En Chu Kong Hospital. With a rich academic background, including a Ph.D. from Taipei Medical University and an MD from National Yang Ming Chiao Tung University, Dr. Huang is a certified expert in Family Medicine, Hospice and Palliative Medicine, and Osteoporosis. His research spans metabolomics, precision medicine, gerontology, and osteoporosis, with numerous publications in reputable journals. 🌊🔬.

Publication Profile

Education

Dr. Chun-Feng Huang earned his Doctor of Medicine degree from the National Yang Ming Chiao Tung University, School of Medicine, Taiwan. He further specialized by obtaining a Ph.D. from Taipei Medical University’s Graduate Institute of Clinical Medicine. Complementing his advanced education, Dr. Huang holds various board certifications: Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis. Additionally, he is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD). His academic journey reflects a deep commitment to continuous learning and specialization in both clinical and research domains, equipping him with a robust foundation to tackle complex medical challenges. Dr. Huang’s educational background not only highlights his expertise in medicine but also underscores his dedication to advancing patient care through education, research, and clinical excellence.

Experience

Dr. Chun-Feng Huang’s career is marked by influential roles in academia and clinical practice. He currently serves as an Assistant Professor at the National Yang Ming Chiao Tung University and Chief of the Department of Family Medicine at En Chu Kong Hospital. Previously, he directed the Department of Family Medicine at the same university hospital from 2016 to 2022. His leadership extended to chairing healthcare services for correctional institutions and community development associations. As Deputy Secretary General and former Prevention Committee Deputy Chairman of the Taiwan Association of Family Medicine, Dr. Huang has shaped national health policies. He also contributed as a Director for the Taipei Smart City IoT Association. His experience in reviewing medical policies for Taiwan’s FDA and involvement in mountain healthcare projects demonstrates his dedication to improving public health systems and addressing diverse healthcare needs through integrated solutions.

Awards and Honors

Dr. Chun-Feng Huang has received numerous accolades for his contributions to medicine and community health. He was recognized with the First Prize at the Annual Academic Conference by the Taiwan Association of Family Medicine in both 2011 and 2018. Between 2010 and 2017, he served as the Principal Investigator for key projects, including the Mountain and Offshore Healthcare Plan and healthcare services for correctional institutions. His leadership was also acknowledged as Chairman of the Yilan County Kang Tai Community Development Association and as Director of the Taipei Smart City IoT Association. His continuous service to healthcare is highlighted by his role as a reviewer for the Taiwan Food and Drug Administration. These awards and honors underscore his commitment to innovation, excellence in family medicine, and the advancement of public health initiatives.

Research Focus

Dr. Chun-Feng Huang’s research centers on metabolomics, precision medicine, gerontology, and osteoporosis. He explores the intricate connections between metabolic pathways and chronic diseases, aiming to develop personalized medical interventions. His work in precision medicine emphasizes tailoring treatments to individual genetic and environmental factors, particularly for elderly populations. In gerontology, he focuses on improving quality of life and functional health outcomes, with a special interest in sarcopenia and cognitive decline. Dr. Huang is also a leading expert in osteoporosis research, contributing to guidelines for fracture prevention and management. His studies include the effects of medications on bone health and the development of innovative treatments to reduce mortality in osteoporosis patients. Through multidisciplinary collaborations, he aims to bridge clinical research with practical healthcare solutions, advancing the understanding and management of age-related diseases.

Conclusion

Dr. Chun-Feng Huang is an outstanding candidate for the Best Researcher Award. His prolific research output, leadership roles, and clinical impact demonstrate excellence and dedication. Addressing the suggested areas for improvement could further elevate his contributions, but his current achievements already position him as a leading figure in his field.

Publication Top Notes

Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach

Authors: CF Huang, ML Cheng, CM Fan, CY Hong, MS Shiao

Citations: 57

Year: 2013

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

Authors: WJ Lee, LN Peng, CH Lin, RC Chen, SZ Lin, CH Loh, SL Kao, TS Hung, …

Citations: 55

Year: 2021

Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes

Authors: YC Chen, YH Kao, CF Huang, CC Cheng, YJ Chen, SA Chen

Citations: 38

Year: 2010

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Authors: TW Tai, CF Huang, HK Huang, RS Yang, JF Chen, TT Cheng, FP Chen, …

Citations: 29

Year: 2023

Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study

Authors: TW Tai, CC Li, CF Huang, WP Chan, CH Wu

Citations: 24

Year: 2022

Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics

Authors: CF Huang, YC Chen, HI Yeh, SA Chen

Citations: 22

Year: 2012

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis

Authors: CH Wu, WC Hung, L Chang, TT Tsai, YF Chang, EV McCloskey, NB Watts, …

Citations: 19

Year: 2020

Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients

Authors: CF Huang, MS Shiao, TY Mao

Citations: 17

Year: 2021

Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model

Authors: CW Lin, CF Huang, JS Wang, LL Fu, TY Mao

Citations: 15

Year: 2020

First insights on value-based healthcare of elders using ICHOM older person standard set reporting

Zhushanying Zhang | Health Professions | Best Researcher Award

Posted on 20/11/202420/11/2024 by ScienceFather

Assist. Prof. Dr. Zhushanying Zhang | Health Professions | Best Researcher Award

Assist. Prof. Dr. Zhushanying Zhang, South-Central Minzu University, China

Dr. Zhushanying Zhang holds a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering, Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led multiple National Natural Science Foundation of China-funded projects and received special funding for basic scientific research. He has published over ten academic papers and holds three invention patents. His work includes advancing Fourier infrared spectroscopy for noninvasive diabetes diagnosis through blood, urine, and saliva samples. 🔬📑💡

Publication Profile

Scopus

Academic and Professional Background

Assist. Prof. Dr. Zhushanying Zhang graduated with a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering at Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led and participated in several research projects funded by the National Natural Science Foundation of China, alongside special funding for basic scientific research from central universities. He has published over ten high-quality academic papers as the first or corresponding author and holds three invention patents. 📚💡📑

Research and Innovations

Assist. Prof. Dr. Zhushanying Zhang has led multiple innovative research projects focused on non-invasive detection technologies. His completed projects include the “Highly Accurate Glucose Detection Using Mid-Infrared Absorption Spectroscopy” (2022-2023, 50,000 Yuan) and “Non-invasive Uric Acid Detection by Near-Infrared Spectroscopy” (2018-2020, 40,000 Yuan), both funded by the Fundamental Research Funds for Central Universities. He also presided over the “Non-invasive Detector for Human Weak Components” (2021-2023, 100,000 Yuan) and “Human Saliva Infrared Spectroscopy Detection” (2022-2023, 500,000 Yuan). His work in Fourier infrared spectroscopy offers promising advancements for diabetes diagnosis using blood, urine, and saliva samples. 🧬📊

Research Areas

Assist. Prof. Dr. Zhushanying Zhang’s research spans across multiple cutting-edge fields. His expertise in infrared spectroscopy and fiber optic sensing focuses on non-invasive medical diagnostics, particularly for glucose and uric acid detection. Utilizing machine learning techniques, he enhances the accuracy and efficiency of sensor data analysis. His work in medical sensing aims to revolutionize healthcare by developing innovative detection technologies. Additionally, Dr. Zhang applies chemometrics to optimize data interpretation, advancing the potential of these technologies for real-world applications, especially in diagnostics and healthcare monitoring. 🔍💡📈

Publication Top Notes

“Advances in Fourier infrared spectroscopy for noninvasive diagnosis of diabetes mellitus: Analysis and prospects for application based on blood, urine, and saliva samples” (2024) 📄
“Precise measurement of human heart rate based on multi-channel radar data fusion” (2024) 📄
“A comprehensively improved local binary pattern framework for texture classification” (2024) 📄
“Identifying the Role of Disulfidptosis in Endometrial Cancer via Machine Learning Methods” (2023) 📄 | Cited by 1
“Quantitative Analysis of Hemoglobin Based on SiPLS-BP Model” (2023) 📄 | Cited by 2
“Texture classification combining improved local binary pattern and threshold segmentation” (2023) 📄 | Cited by 12
“Mid-infrared spectroscopy with an effective variable selection method based on MPA for glucose detection” (2023) 📄 | Cited by 5
“Influencing Factors of Mid-Infrared Spectrum Blood Glucose Detection” (2023) 📄 | Cited by 2
“Quantitative Analysis of Hemoglobin Based on SiPLS-SPA Wavelength Optimization” (2023) 📄 | Cited by 3
“Thermal performance of LED filament in flip-chip packaging manufactured for different correlated color temperature” (2021) 📄 | Cited by 1

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Posted on 04/11/202404/11/2024 by ScienceFather

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

Publication Top Notes

A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

Fei Yu | Medicine and Dentistry | Best Researcher Award

Posted on 29/10/202429/10/2024 by ScienceFather

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Posted on 23/09/202423/09/2024 by ScienceFather

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.

Publication top notes

Novel Biomarkers and Molecular Targets in ALL

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Posted on 06/09/202406/09/2024 by ScienceFather

Dr. khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Dr. khadijeh kalanfarmanfarma, Kashan University of Medical Sciences, Kashan, Iran

Dr. Khadijeh Kalan Farmanfarma (born April 24, 1978) holds a PhD in Epidemiology and an M.Sc. in Health Education and Promotion. She has been recognized as a top researcher at both the national and university levels, notably at Zahedan University of Medical Sciences. Dr. Farmanfarma has contributed to over 20 high-impact publications, focusing on cancer epidemiology, metabolic syndrome, and public health. She is also a co-author of an eBook on the Renin-Angiotensin System and its role in diseases. Her research has earned her awards and recognition both nationally and internationally. 📚🌍🔬

Publication profile

Scopus

Google Scholar

Academic Background 🧠

Dr. Khadijeh Kalan Farmanfarma holds a PhD in Epidemiology and an M.Sc. in Health Education and Health Promotion. Her solid academic foundation is supported by multiple recognitions at the doctoral and master’s levels. Her focus on epidemiological research is crucial, particularly during global health challenges like COVID-19.

Research Contributions 📚

Dr. Farmanfarma has an impressive body of work, with more than 25 published research articles across Q1 to Q3 journals. Some highlights include:

COVID-19 Research: Her studies on the impact of COVID-19, especially on domestic violence and illness anxiety, show her commitment to addressing emerging public health issues.

Metabolic Syndrome & Cancer Epidemiology: Dr. Farmanfarma has published meta-analyses on metabolic syndrome and various cancers, which have gained significant attention in high-impact journals like Diabetes & Metabolic Syndrome: Clinical Research & Reviews (IF: 10.0, Q1).

Chronic Diseases & Breast Cancer Prevention: Her focus on chronic diseases and breast cancer prevention demonstrates her dedication to improving population health.

Recognitions 🏆

Dr. Farmanfarma’s accolades include being named the Top National Researcher and Top Researcher at Zahedan University of Medical Sciences multiple times, which speaks to her consistent excellence in research.

Publication Top Notes

📚 Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies – Cited by: 248 (2018)
📚 Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies – Cited by: 149 (2019)
🧠 Brain cancer in the world: An epidemiological review – Cited by: 79 (2019)
🎗️ Improving Breast Cancer Preventive Behavior among Female Medical Staff: Educational Intervention – Cited by: 59 (2014)
📊 Epidemiologic study of gastric cancer in Iran: A systematic review – Cited by: 51 (2020)
📈 Prevalence of type 2 diabetes in Middle-East: Systematic review & meta-analysis – Cited by: 47 (2020)
🎗️ Effect of education on preventive behaviors of breast cancer in female teachers – Cited by: 35 (2014)
🩺 Study of breast cancer knowledge, attitude, and preventive behaviors in Yazd, Iran – Cited by: 22 (2017)
📊 Prevalence and trend of metabolic syndrome in South-East Iran – Cited by: 21 (2020)
🧬 Testicular cancer in the world: An epidemiological review – Cited by: 20 (2018)

Conclusion 📝

With her extensive research output, recognitions, and focus on significant public health issues, Dr. Khadijeh Kalan Farmanfarma is a strong candidate for the Research for Best Researcher Award. Her diverse and impactful research contributions in epidemiology, particularly in chronic diseases and cancer, reflect a distinguished career deserving of recognition.

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Posted on 23/08/202423/08/2024 by ScienceFather

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

Research focus

The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Posted on 29/07/202429/07/2024 by ScienceFather

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Dr Mohammadamin Parsaei, Maternal, Fetal & Neonatal Research Center, Iran

Dr. Mohammadamin Parsaei is a prominent academic and researcher specializing in [specific field]. He holds a [degree] from [institution] and has extensive experience in [area of expertise]. Dr. Parsaei is known for his contributions to [specific research focus or project], with numerous publications and impactful research outcomes. He is currently affiliated with [institution] as a [position], where he continues to advance knowledge in [field]. His work is widely recognized for its innovation and excellence. 📚🔬

Publication profile

google scholar

Education

Dr. Mohammadamin Parsaei earned their Doctor of Medicine degree from Tehran University of Medical Sciences in 2023, with a GPA of 3.68/4. Their thesis, titled “Assessing Clinical Outcomes of Adrenalectomy and Associated Factors: A Retrospective Study in Iran,” was successfully defended before the General Surgery faculty at Dr. Shariati Hospital, Tehran University of Medical Sciences. This research delves into the clinical outcomes of adrenalectomy procedures and explores the associated factors affecting patient outcomes in Iran. 🏥📚👩‍⚕️

Experience

Dr. Mohammadamin Parsaei is a Postdoctoral Research Fellow at the Maternal, Fetal & Neonatal Research Center, Family Health Research Institute, Tehran University of Medical Sciences (2023-present). In this role, Dr. Mohammadamin Parsaei conducts clinical trials, observational studies, and reviews in Obstetrics and Gynecology, Infertility, and Maternal-Fetal research. Responsibilities include statistical analysis, overseeing research projects, crafting proposals, and managing article submissions. Additionally, Dr. [Name] serves as a Research Supervisor at ResearchPlus Academy (2024-present) and NCWEB Association (2023-present), leading systematic reviews and meta-analyses in multidisciplinary fields and neuroradiology. 🧪📊🔬

Research focus

The research of M. Parsaei predominantly focuses on psychiatric and psychological disorders, neuroimaging, and reproductive health. Key areas include the efficacy and safety of psychiatric medications, the impact of neuroimaging on mental health conditions like schizophrenia and social anxiety disorders, and the role of various interventions in managing these conditions. Parsaei’s work also extends to evaluating treatments for reproductive health issues, such as ectopic pregnancies, and the effects of maternal obesity on offspring brain development. This diverse research contributes to understanding and improving mental health, neuroimaging techniques, and reproductive outcomes. 🧠🔬💊👶

Publication top notes

Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial

Classification of suicidality by training supervised machine learning models with brain MRI findings: A systematic review

White matter alterations in affective and non-affective early psychosis: A diffusion MRI study

Methotrexate as the first-line treatment of unruptured tubular ectopic pregnancies with high initial human chorionic gonadotropin levels: A retrospective cohort

Effects of non-pharmacological interventions on gait and balance of persons with Multiple Sclerosis: A narrative review

Microstructural white matter alterations associated with social anxiety disorders: A systematic review

Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial

Machine Learning for Prediction of Violent Behaviors in Schizophrenia Spectrum Disorders: A Systematic Review

White matter correlates of impulsive behavior in healthy individuals: A diffusion MRI study

Predicting the Outcomes of In Vitro Fertilization Using Baseline Maternal Serum Inflammatory Markers: A Retrospective Cohort Study

Enguo Cao | Health Professions | Best Researcher Award

Posted on 24/07/202424/07/2024 by ScienceFather

Enguo Cao | Health Professions | Best Researcher Award

Prof Dr Enguo Cao, Jiangnan University, China

Prof. Cao Enguo 🧑‍🏫 is a distinguished professor and doctoral supervisor at Jiangnan University, China. With a Ph.D. from Japan, he leads the Intelligent Interaction Design Laboratory and serves as deputy director of the Key Laboratory of China Light Industry. His research focuses on intelligent product design and human biomimetic interaction, resulting in over 30 papers and 20+ patents. He has led numerous research projects, including grants from the National Natural Science Foundation of China. Prof. Cao has earned several accolades, including the Yoneyama Rotary Memorial Award and the title of “Top Six Talent Peaks” in Jiangsu Province. 🌟🔬📚

Publication profile

Scopus

Research Interests

Intelligent Interaction System Design focuses on creating advanced systems that enhance user experiences through smart and responsive technology. This field encompasses the development of interactive interfaces that adapt to user needs, leveraging artificial intelligence and machine learning to offer intuitive and personalized interactions. The goal is to build systems that not only respond to user inputs but also predict and adapt to their preferences, providing a seamless and engaging experience. Such designs are pivotal in various applications, from smart home devices to sophisticated customer service bots, aiming to make technology more accessible and user-friendly.

Research focus

Dr. Enguo Cao’s research primarily focuses on wearable health devices, exoskeleton design, and user experience in robotics. His work includes designing and evaluating various types of exoskeletons for rehabilitation and mobility enhancement, such as passive lower limb exoskeletons and multi-resiliency models. He also explores the integration of emotional and social factors into user experience, aiming to improve interaction with automated systems and devices. His contributions include studies on the physiological effects of exoskeletons during physical activities and data-driven frameworks for predicting user expectations. His research is crucial for advancing assistive technologies and enhancing their practical application. 🤖🦵📊